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Abstract
The evolutionary reason for the increase in gene length from archaea to prokaryotes
to eukaryotes observed in large scale genome sequencing efforts has been unclear.
We propose here that the increasing complexity of protein-protein interactions has
driven the selection of longer proteins, as longer proteins are more able to distinguish
among a larger number of distinct interactions due to their greater average surface
area. Annotated protein sequences available from the SWISS-PROT database were
analyzed for thirteen eukaryotes, eight bacteria, and two archaea species. The num-
ber of subcellular locations to which each protein is associated is used as a measure
of the number of interactions to which a protein participates. Two databases of yeast
protein-protein interactions were used as another measure of the number of inter-
actions to which each S. cerevisiae protein participates. Protein length is shown to
correlate with both number of subcellular locations to which a protein is associated
and number of interactions as measured by yeast two-hybrid experiments. Protein
length is also shown to correlate with the probability that the protein is encoded
by an essential gene. Interestingly, average protein length and number of subcellu-
lar locations are not significantly different between all human proteins and protein
targets of known, marketed drugs. Increased protein length appears to be a signif-
icant mechanism by which the increasing complexity of protein-protein interaction
networks is accommodated within the natural evolution of species. Consideration
of protein length may be a valuable tool in drug design, one that predicts different
strategies for inhibiting interactions in aberrant and normal pathways.
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1 Introduction
It has been noticed that genomes from the various domains of life differ greatly
in size. For example, the human genome is roughly 30 times larger than that
of the Drosophila. It has also been noticed that protein lengths vary system-
atically within the three domains of life [1]. The eukaryote domain is found to
have the longest average protein length per genome, while the archaea domain
is found to have the shortest average protein length per genome. Investiga-
tions to date have not been able to pinpoint the biological significance or
evolutionary mechanism for these observations.
Following a suggestion in [1], we here propose that protein lengths are cor-
related with genome size in order to cope with the increased complexity of
protein-protein interactions that arises within larger genomes. Examples of
increased complexity and functionality associated with larger systems abound
in engineering and biology. In the highly-optimized tolerance theory of Doyle,
complexity of an engineering or biological system is postulated to be a require-
ment of robustness [2]. It is implicitly assumed in this theory that selection
for increased robustness leads to larger, and more complex, systems. In sim-
ple liquid crystals, incorporation of additional molecular species can lead to
the formation of new phases [3]. In materials science, it is well-known that
the number of possible material phases increases dramatically with the num-
ber of elements present [4]. In protein structural biology, it is known that a
finite number of distinct amino acids, more than two and typically on the
order of five, is required to reproduce characteristic protein structures [5]. In
polymer physics, the complexity of material phases increases greatly as consid-
eration is expanded from homopolymers to diblock copolymers [6] to triblock
polymers [7]. Organization of the collective dynamics of social networks, the
internet, or traffic flow into so-called small world networks allows for efficient
communication within large systems [8]. The latter finding is relevant in the
present context, because interactions between proteins have been shown to
increase with the number of proteins present at a rate that is consistent with
small-world-network theory [9].
In this paper, we show that a positive correlation exists between protein length
and the number of subcellular locations in which a protein is found. For yeast,
we shown additionally a positive correlation between protein length and num-
ber of observed protein-protein interactions. This positive correlation of com-
plexity with length supports the hypothesis that an increase in protein length
is necessary for an increased number of specific interactions, on average. The
positive correlation is shown to exist for prokaryotes and eukaryotes. Based
upon these considerations of length, it is shown that most single-drug protein
inhibitors are inhibiting a particular receptor or target site on a protein, rather
than knocking out the whole protein.
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Methods and Results
Protein length comparisons across the three domains of life were performed
utilizing the Meta-A annotation of the SWISS-PROT database [10]. This al-
lowed determination of lengths of expressed proteins. The average protein
lengths were determined for each organism whose genome had a large number
of completely sequenced expressed proteins. The standard error estimate of
the average was also calculated. Thirteen eukaryotes, eight bacteria, and two
archaea were analyzed for comparisons of protein length for the entire genome.
These species were chosen because they have the highest frequency of entries in
the SWISS-PROT database. The Meta-A database was made non-redundant
by removing entries with different accession numbers but identical sequences
as returned by a SWISS-PROT FASTA query [11], of which there were very
few. Accession numbers that corresponded to protein fragments were also re-
moved. Shown in table 1 are the numbers of proteins used within each species.
The Meta-A annotation determines with which subcellular locations each pro-
tein is associated. This number of subcellular locations is used as one mea-
sure of the number of interactions in which a protein participates. Thus, the
data from the analysis of the SWISS-PROT database is separated according
to each organism and according to the domain of life, archaea, bacteria, or
eukaryote, to which the organism belongs. Each protein of the organism is
then categorized according to how many subcellular locations to which it is
associated. The possible subcellular locations are intracellular, membrane re-
lated, extracellular, cytoplasmic, transmembrane, mitochondrial, chloroplast,
nuclear, endoplasmic reticulum/Golgi apparatus, viral, and DNA binding. For
the archaea domain the number of locations ranges from one to four, for the
bacteria domain the number ranges from one to six, and for the eukaryote do-
main the number ranges from one to seven. The locations nuclear, mitochon-
drial, chloroplast and ER/Golgi are available only for the eukaryote proteins.
There is no protein that is associated with all of the compartments for bacte-
ria and eukaryotes. The number of amino acids in each protein is downloaded
from SWISS-PROT. The average length of a protein is correlated by a linear
least squares fit with the number of subcellular locations for each species (a
non-linear correlation does not substantially better represent the data). The
standard error estimate of the slope of the correlation (and t-statistic) was
calculated. The number of domains contained within each protein was also
calculated, using the Pfam database (swisspfam datafile) [12], and correlated
by a linear least squares fit with the number of subcellular locations. The
standard error estimate of the slope of the correlation (and t-statistic) was
calculated.
Number of protein interactions for S. cerevisiae is determined from two databases,
the updated data of Uetz et al. [13] and the comprehensive MIPS database
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[14]. The number of protein-protein interactions was correlated with protein
length by a linear least squares fit, and the standard error estimate of the
slope of the correlation (and t-statistic) was calculated. It was necessary to
make the set of associated interacting proteins non-redundant for each protein
within MIPS. For both Uetz et al. and MIPS, all proteins with greater than
zero interactions were used, starting from those within the Meta-A dataset.
These data were used to correlate protein length directly with number of inter-
actions. Those proteins within the Meta-A protein dataset that are essential
were determined from the Saccharomyces Genome Deletion Project [15]. The
relationship between protein length and the probability that the encoding gene
is essential was determined. The standard error estimate of the probability was
also calculated.
Finally, a list of protein targets of known, marketed drugs was constructed by
selecting from the Harvard Small Molecule Bioactives Database [16] those com-
pounds that targeted a specific protein which could be identified in SWISS-
PROT. Of the greater than 2000 compounds in the database, 186 targeted a
specific protein, of which 100 were unique. The number of drug targets is in
agreement with Pfizer’s proprietary list of protein drug targets, which contains
120 unique proteins [17].
Figure 1 shows the plot of the average protein lengths for the various genomes
across the three domains of life. The mean values of the protein lengths de-
crease from eukaryote to bacteria to archaea. This trend in protein lengths is
identical to that previously observed for gene lengths [1].
Figure 2 shows a positive correlation between average protein length and num-
ber of associated subcellular locations for the bacteria domain. Figure 3 shows
a positive correlation between average protein length and number of associ-
ated subcellular locations for the eukaryote domain. Positive correlations are
found for all thirteen eukaryote species shown in figure 3. A similar correlation
was not found for the archaea domain (data not shown). Also shown in figures
2 and 3 are the correlations between number of domains within a protein and
number of associated subcellular locations.
The probability that a protein of a given length will be encoded by an essential
gene is shown in figure 4. A positive correlation is found between length and
essentiality.
The number of interactions for yeast proteins of various lengths is shown in
figure 5. Since the data become sparse for large numbers of interactions, only
those proteins with fewer than a dozen interactions are shown.
The average lengths and number of subcellar locations of human proteins are
shown in table 2, along with these same quantities for the protein targets of
marketed drugs.
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Discussion
That proteins must be longer in order to achieve and distinguish among an
increased number of interactions is a mechanistic explanation for the positive
correlations found in bacteria and eukaryotes. At a more coarse-grained level,
comparisons between human, fly, worm, and yeast have shown that the human
proteome set contains 1.8 times as many protein domains as the worm or fly
and 5.8 times as many as yeast [18]. Moreover, the average eukaryote gene
length is roughly 1.4 times the average bacterial gene length and 1.6 times
the average archaea gene length [1]. The increase in the number of domain
architectures and genome complexity correlates with the observed increase in
protein length. The larger vocabulary of protein domain architectures allows
the more evolved systems to accommodate an increased number of interac-
tions.
The results in figures 2 and 3 are statistically significant. Most significant is
that if one assumed the correlations were random, with a slope symmetrically
distributed about zero, the probability that 20 or more out of 21 of these
correlations would be positive is [(21
21
) + (21
20
)] 2−21 = 10−5. Taken in aggregate,
therefore, figures 2a and 3a suggest that there is a highly significant and
positive correlation between protein length and number of subcellular locations
to which a protein is associated. At the level of each individual correlation,
the average t-statistic for the positive correlations in figure 2a is 1.80, and
that of figure 2b is 0.87. The average R values are 0.64 and 0.44, respectively.
The average t-statistic for the positive correlations in Figure 3a is 2.46, and
that of figure 3b is 2.70. The average R values are 0.80 and 0.65, respectively.
Interestingly, the correlations for the eukaryotes are somewhat more significant
(P = 0.014 for figure 3a) than those for the bacteria (P = 0.072 for figure 2a).
For the bacteria, the correlations with protein length observed in figure 2a
are slightly more significant than the the correlations with number of domains
observed in figures 2b. For the eukaryotes, the correlations with protein length
are of roughly the same significance as those with number of domains.
An alternative means of correlating length with number of locations would
be to use all of the protein entries, rather than preaverage them within each
location, as in figures 2a and 3a. When this is done for the bacteria, the
positive correlations persist, except for Aquifex aeolicus, Bacillus substilis, and
Synechocystis sp. Similarly, when this is done for the eukaryotes, the positive
correlations persist, except for Saccharomyces cerevisiae. Overall, then, the
trend of increasing number of interactions with increasing length among the
prokaryotes and eukaryotes is rather robust to the means of measurement. The
average t-statistic for the positive correlations determined by this method for
the analog of Figure 2a is 2.5035, and the average t-statistic for the positive
correlations determined by this method for the analog of figure 3a is 6.454,
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with the increased significance due to the greater number of data points.
The topological scaling properties of metabolic networks of organisms show
similarities to complex systems in general [19]. The topology of these scale-free
networks is dominated by highly-connected nodes, “hubs,” that link together
the less-connected nodes. Deletion of these hubs is an especially efficient way
to destroy the connectivity of the network [20]. From our results, the hub
proteins of large protein-protein networks are more likely to be the longer
proteins, since we have shown that longer lengths typically possess more inter-
protein interactions. Figure 4, moreover, explicitly shows that longer proteins
are more essential, precisely because they are more connected [21].
As shown in table 2, protein targets of known drugs are not substantially
shorter or less numerous in number of subcellular interactions than are average
human proteins. Given the above arguments about protein-protein networks,
this lack of difference might seem surprising [22]. What this result implies,
in fact, is that most known single-drug protein inhibitors are inhibiting a
particular receptor or target site on a protein, rather than knocking out the
whole protein.
If it is desired to disrupt a pathway with many distinct interactions, most likely
the best proteins to knock out will be the longer ones. Therefore, it may be
advisable for multiple drug regimen therapies that target aberrant pathways
to target multiple receptors of the longest proteins of those pathways, within
the set of otherwise equally suitable targets. However, if minimal disruption
of a normal pathway is desired, the focus of the therapy should be on the
smaller proteins or single-drug therapies. These smaller, shorter proteins are
less likely to be at the center of network pathway hubs, and their deletion
would be least likely to disrupt the network, all other factors being equal. From
an evolutionary point of view, shorter proteins with fewer interactions would
more readily be independently evolved, having fewer epistatic interactions
[23]. Directed pathway evolution studies may benefit from a focus on such
proteins [24].
It might be argued that number of subcellular locations is only an approxi-
mate measure of the number of interactions to which a protein participates.
For yeast, there are explicit measurements of the number of protein-protein
interactions. Shown in figure 5 is the positive correlation between length and
number of interactions determined in yeast when all of the proteins with en-
tries in SWISS-PROT are correlated. The correlation in figure 5a is significant
to the level P = 0.05 (t-statistic = 1.95), and the correlation in figure 5b is
significant to the level P = 6 × 10−8 (t-statistic = 5.425). The R values are
0.24 and 0.32, respectively. The positive correlation in figure 5 is in accord
with the positive correlation found for yeast in figure 3a, and this agreement
provides additional justification for the use of number of subcellular locations
6
as a surrogate measure of number of protein interactions. There are, of course,
exceptions to the general correlation between protein length and number of
interactions. For example, a large number of proteins can interact with a spe-
cific short protein if all the interactions occur through the same binding site.
This appears to be the case for several single-domain RNA- and DNA-binding
proteins (such as SOH1, LSM2, RPB9, LSM5, and SR14). The single-domain
GTP-binding protein (TEM1) as well as the membrane proton channel (AT14)
of the ATPase complex are also short and bind many proteins. Notwithstand-
ing these and other exceptions, the correlations in figure 5 are striking, and
the positive correlation persists even when data for all numbers of interactions
are considered (data not shown).
The positive correlations observed in the bacteria and eukaryote domains were
not observed in the archaea domain. The correlations for the archaea remain
negative also when all proteins are used in the correlation. Archaea have sub-
stantially fewer subcellular locations and total numbers of proteins. It is also
evident from figure 1 that the archaea domain possesses the shortest proteins.
The archaea domain, being the least evolved, may, therefore, lack the necessary
diversity of protein-protein interactions necessary to drive the evolution of the
increased protein lengths observed in the bacteria and eukaryote domain.
Conclusions
Increased protein length appears to be a significant mechanism by which
the increasing complexity of protein-protein interaction networks is accom-
modated within the natural evolution of species. It would be interesting to
measure within experimental evolution protocols [24] the degree to which se-
lection for an increased number of specific interactions within various pathways
or subsystems is a major driver of increased protein length. It also appears
that consideration of protein length may be a valuable tool in drug design,
one that predicts different strategies for inhibiting interactions in aberrant and
normal pathways.
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Fig. 1. Mean protein length for the various genomes of the eukaryote, bacteria,
and archaea domain. The eukaryotes studied were Arabidopsis thaliana (Ath), Bos
taurus (Bta), Caenorhabditis elegans (Cel), Drosophila melanogaster (Dme), Gal-
lus gallus (Gga), Homo sapien (Hsa), Mus musculus (Mmu), Oryctolagus cunicu-
lus (Ocu), Rattus norvegicus (Rno), Saccharomyces cerevisiae (Sce), Schizosaccha-
romyces pombe (Spo), Sus scrofa (Ssc), and Xenopus laevis (Xla). The bacteria stud-
ied were Aquifex aeolicus (Aae), Bacillus subtilis (Bsu), Escherichia coli (Eco), My-
cobacterium leprae (Mle), Mycobacterium tuberculosis (Mtu), Pseudomonas aerugi-
nosa (Pae), Salmonella typhimurium (Sty), and Synechocystis sp. (strain PCC 6803)
(Syn). The archaea studied were Archaeoglobus fulgidus (Afu) and Methanococcus
jannaschii (Mja). The smallest estimate of the error was 3.63 and the largest was
17.64 amino acids, with an average estimate of the error of 9.02 amino acids. After
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Fig. 2. Correlation with number of subcellular locations for the bacteria domain.
Positive correlation for the bacteria domain between a) protein length or b) number
of domains within a protein and number of subcellular locations. Only Mycobac-
terium tuberculosis has a negative slope in the correlations.
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Fig. 3. Correlation with number of subcellular locations for the eukaryote domain.
Positive correlation for the eukaryote domain between a) protein length or b) num-
ber of domains within a protein and number of subcellular locations.
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Fig. 4. Correlation with essentiality for yeast proteins. Positive correlation between
the length of yeast protein and the probability that the encoding gene is essential.
Within each bin of protein length, the fraction of such proteins that are essential
as determined by knock-out experiments [15] is plotted.
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Fig. 5. Correlation of protein-protein interactions in yeast. Positive correlation for
yeast between the number of protein-protein interactions and protein length. Data
from a) [13] and b) [14].
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Table 1
Number of proteins annotated by Meta-A for each species.
Species Number of Proteins
Eukaryotes
Ath 1313
Bta 1015
Cel 1333
Dme 1383
Gga 833
Hsa 6608
Mmu 4227
Ocu 534
Rno 2572
Sce 3394
Spo 1319
Ssc 535
Xla 648
Bacteria
Aae 496
Bsu 1635
Eco 3478
Mle 424
Mtu 943
Pae 527
Sty 733
Syn 694
Archaea
Afu 481
Mja 769
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Table 2
Length and number of subcellular locations. Data are shown for all human pro-
teins and for protein drug targets Standard error estimates are calculated from one
standard deviation.
All Human Proteins Targeted Non-redundant
Proteins by Drugs Protein Targets
Number of Proteins 6608 186 100
Average Length 523 ± 5.98 577 ± 22.5 554 ± 34.0
Average Number of Locations 2.68 ± 0.02 2.64 ± 0.11 2.72 ± 0.15
Average Number of Domains 3.06 ± 0.03 3.22 ± 0.14 3.26 ± 0.23
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